 |
 |

Combined Use of Neostigmine and Ocular Motility Measurements in the Diagnosis of Myasthenia Gravis
Neil R. Miller, MD;
Jacqueline E. Morris, CO;
Maureen Maquire, ScM
Arch Ophthalmol. 1982;100(5):761-763.
Abstract
Forty-four patients with diplopia caused by myasthenia gravis, ocular myopathies, and ocular motor nerve palsies underwent complete orthoptic evaluations before and after intramuscular injection of neostigmine (Prostigmin) methylsulfate. A test score combining the results of binocular and uniocular measurements was developed that allowed correct classification of 70% (31) of patients studied.
Author Affiliations
From the Neuro-ophthalmology Unit, the Wilmer Ophthalmological Institute, The Johns Hopkins Hospital, Baltimore.
Footnotes
Accepted for publication May 29, 1981.
Reprint requests to Neuro-ophthalmology Unit, the Wilmer Ophthalmological Institute, The Johns Hopkins Hospital, 601 N Broadway, Baltimore, MD 21205 (Dr Miller).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|